First National Bank of South Miami’s Regeneron Pharmaceuticals REGN Stock Holding History

First National Bank of South Miami’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7	Closed	-$5K	–	273
2022 Q4	$5K	Hold	7	–	–	﹤0.01%	258
2022 Q3	$5K	Sell	7 -8	-53%	-$5.04K	﹤0.01%	260
2022 Q2	$9K	Sell	15 -53	-78%	-$34.5K	0.01%	261
2022 Q1	$47K	Sell	68 -138	-67%	-$87.3K	0.03%	220
2021 Q4	$130K	Buy	206 +58	+39%	+$35.7K	0.08%	168
2021 Q3	$90K	Buy	+148	New	+$91.9K	0.06%	178
2021 Q1	–	Sell	-10	Closed	-$5K	–	316
2020 Q4	$5K	Hold	10	–	–	﹤0.01%	266
2020 Q3	$6K	Hold	10	–	–	0.01%	245
2020 Q2	$6K	Hold	10	–	–	0.01%	251
2020 Q1	$5K	Buy	+10	New	+$4.13K	0.01%	245

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First National Bank of South Miami's REGN Position: Q1 2023 in Review

First National Bank of South Miami sold out of Regeneron Pharmaceuticals (REGN) in Q1 2023, closing a stake of 7 shares — an estimated $5K sold.

First National Bank of South Miami first reported a position in REGN in Q1 2020 and held it in 10 quarters. The position peaked at $130K in Q4 2021. 1,193 funds tracked by Wall St. Rank hold REGN as of Q1 2023.

First National Bank of South Miami reported no remaining Regeneron Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
First National Bank of South Miami sold 7 Regeneron Pharmaceuticals shares in Q1 2023, an estimated $5K.
First National Bank of South Miami first reported a position in Regeneron Pharmaceuticals in Q1 2020 and held it in 10 quarters.
First National Bank of South Miami's Regeneron Pharmaceuticals position peaked at $130K in Q4 2021.
1,193 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2023.

Based on First National Bank of South Miami's 13F filing for Q1 2023, filed 17 Apr 2023.